Targeting lipid enzymes triggers starvation states in aggressive tumor cells
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for…
Team finds markers of inflammatory breast cancer in blood
Share this Article You are free to share this article under the Attribution 4.0 International license. Researchers have…
New study reveals nitric oxide’s widespread impact on genetics
Genes undergo extensive editing through a process called alternative splicing, which greatly increases the size of the functional…
Scientists capture immune cells attacking live melanoma cells in real time
Scientists at the Garvan Institute of Medical Research have captured, for the first time, ‘housekeeping’ immune cells actively…
Experimental virus therapy targets resistant high-grade neuroendocrine tumors
A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against…
Researchers Identify Drivers of Resistance to KRAS Inhibitors in Colorectal Cancer
Colorectal cancer can resist KRAS inhibitors in both genetic and non-genetic waysAn early inflammation surge within days of…
Predicting cancer outcomes with a selfie — Harvard Gazette
Researchers using artificial intelligence to plumb links between biological age and cancer outcomes have linked both looking younger…
New gene expression signature may guide immunotherapy for resistant prostate cancer patients
Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a…
Small T-cell subset drives powerful multiple myeloma immunotherapy responses
Researchers from The University of Osaka find that only a small fraction of T cells may drive the…
Light-driven nanomotors improve multimodal breast cancer treatment efficacy
The nanomotor starts with bowl‑shaped mesoporous polydopamine (PDA) nanoparticles. These biocompatible bowls are loaded with two key payloads:…
Polymer-based immunotherapies enhance tumor targeting and immune activation
Conventional immune checkpoint inhibitors, such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, can reinvigorate T cells but typically benefit less…
Restoring ADAR2 enzyme reduces metastatic spread in osteosarcoma
Osteosarcoma is the most common primary bone cancer in children, adolescents, and young adults. Although chemotherapy and surgery…